Richard J. Mazour Dds Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 801 W. Court St., Beatrice, NE 68310 Phone: 402-223-5109 Fax: 402-223-5310 |
Woodward & Villafane Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 801 West Court Street, Beatrice, NE 68310 Phone: 402-223-2139 Fax: 402-223-4348 |
Plaza Ridge Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 110 Eastside Blvd, Beatrice, NE 68310 Phone: 402-223-4140 Fax: 402-228-1762 |
Gleason Family Dental Clinic, P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 512 Lincoln St, Beatrice, NE 68310 Phone: 402-228-3119 Fax: 402-228-3350 |
News Archive
In the United States, nearly 15 million people and 1 in 13 children suffer from food allergy. In Arizona alone, every classroom contains at least two children with a food allergy. Soybeans are one of the eight foods regulated by the Food Allergen Labeling and Consumer Protection Act, or FALPA. Soybean is a major ingredient in many infant formulas, processed foods and livestock feed used for agriculture. Soybeans contain several allergenic and anti-nutritional proteins that affect soybean use as food and animal feed.
The International Society on Thrombosis and Haemostasis (ISTH), in partnership with John Wiley and Sons, Inc., announces the launch of the Society's new open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH), with its inaugural issue to publish in conjunction with the meeting of the ISTH 2017 Congress in Berlin, Germany, July 8-13.
"How long do I have, doctor?" For many cancer patients, following the initial shock of their diagnosis, thoughts quickly turn to estimating how much precious time they have left with family and friends or whether certain treatments could prolong their life.
Micronics, Inc. today announced that it has been issued two patents from the United States Patent and Trademark Office (USPTO) for novel microfluidic devices and methods. These new patents relate to the company's focus on the development of rapid and easy to use clinical diagnostic products.
Quanterix announced that it has commenced an underwritten public offering of $75 million of shares of its common stock.
› Verified 9 days ago